immunity News and Research

RSS

FDA issues Emergency Use Authorization for multiplex Zika test

The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.

14 Aug 2017

Nanotechnology wonders: Organ healing with a single touch!

Scientists from the Ohio State University Wexner Medical Centre have come up with what sounds like a science fiction - a nanotechnology device that can switch the cell functions in such a way that the failing organs are revived using a single touch.

7 Aug 2017

Prior flavivirus disease does not worsen Zika infection in rhesus macaques

Rhesus macaques previously infected with dengue or yellow fever viruses appear to be neither more nor less susceptible to severe infection with Zika virus, according to new research published in PLOS Pathogens.

4 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

UM SOM researchers to study adaptive immune responses of infants with HIV exposure in utero

The University of Maryland School of Medicine's Institute for Global Health and the Institute of Human Virology have been awarded a $2 million five-year grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study the impact exposure to HIV has on the immune systems of infants in utero and how those changes impact the ability of infants to fight off infections after birth.

2 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Sexual transmission of Zika virus reported in Florida

Yesterday, Florida Department of Health reported the first case of sexually transmitted Zika virus this year.

2 Aug 2017

Researchers highlight role of micro-guests in pathologic processes

We host more microbiota than our own cells. These micro-guests produce metabolites that are only beginning to be appreciated as important factors in pathologic processes, from chronic inflammatory diseases to preterm birth.

1 Aug 2017

Inflammatory biomarkers may help diagnose chronic fatigue syndrome

Researchers have discovered inflammation biomarkers that could help scientists to research, diagnose and even treat chronic fatigue syndrome (CFS). Also referred to as myalgic encephomyelitis, CFS is a poorly-understood condition characterized by profound, long-term tiredness.

1 Aug 2017

Biomedical researcher wins $1.9 million federal grant to develop enhanced influenza vaccines

Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has renewed a four-year, $1.9 million federal grant to develop influenza vaccines that offer enhanced protection against a broad range of influenza virus strains.

31 Jul 2017

Gut bacterium can stop chemotherapy from causing cancer cell death

Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes.

27 Jul 2017

Multistate Salmonella outbreak linked to Maradol Papaya: CDC reports

A total of 47 people have been infected with Salmonella Kiambu infections from 12 different states as of 21st July 2017, reports the CDC. Of these, 12 have had to be hospitalized and one person from New York City succumbed to the infection. Maradol papayas have been found to be the likely source of this infection and the CDC has recommended people not to consume these until its clear.

24 Jul 2017

Genetic variation linked to greater tuberculosis susceptibility

Researchers have shown that a single nucleotide change in a gene that affects production of hepcidin--a peptide involved in inflammation, immunity, and control of iron levels--is associated with greater susceptibility to extrapulmonary tuberculosis.

21 Jul 2017

UAlberta researchers find strong clues to underlying cause of HIV-associated neurocognitive disorders

UAlberta researchers believe they now have a clearer picture of why people living with HIV so commonly suffer from dementia and other neurocognitive disorders.

20 Jul 2017

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University.

19 Jul 2017

Study: Breast cancer patients receiving neoadjuvant radiation have lower risk of second primary tumor

Moffitt Cancer Center researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery (neoadjuvant) or after surgery (adjuvant).

17 Jul 2017

CNIC research holds potential to improve current cancer immunotherapy strategies

Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III have investigated how different subtypes of essential immune-response cells called CD8+ T lymphocytes cooperate to mount a stronger anti-tumor response.

17 Jul 2017

Prior dengue fever in people infected by Zika does not lead to worse illness

Individuals who are infected by Zika virus after having dengue fever do not appear to become more severely ill than people with Zika who have never had dengue.

14 Jul 2017

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient’s own genes would be modified to fight the cancer cells. The patient’s cells which are thus altered to treat the cancer would thus be termed as “living drugs” as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

14 Jul 2017

Researchers synthesize nanoparticles with superior antioxidant properties to treat sepsis

With an incidence of 31.5 million worldwide and a mortality of around 17%, sepsis remains the most common cause of death in hospitalized patients, even in industrialized countries where antibiotics and critical care facilities are readily available.

12 Jul 2017

immunity News and Research

FDA issues Emergency Use Authorization for multiplex Zika test

Nanotechnology wonders: Organ healing with a single touch!

Prior flavivirus disease does not worsen Zika infection in rhesus macaques

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

UM SOM researchers to study adaptive immune responses of infants with HIV exposure in utero

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Sexual transmission of Zika virus reported in Florida

Researchers highlight role of micro-guests in pathologic processes

Inflammatory biomarkers may help diagnose chronic fatigue syndrome

Biomedical researcher wins $1.9 million federal grant to develop enhanced influenza vaccines

Gut bacterium can stop chemotherapy from causing cancer cell death

Multistate Salmonella outbreak linked to Maradol Papaya: CDC reports

Genetic variation linked to greater tuberculosis susceptibility

UAlberta researchers find strong clues to underlying cause of HIV-associated neurocognitive disorders

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

Study: Breast cancer patients receiving neoadjuvant radiation have lower risk of second primary tumor

CNIC research holds potential to improve current cancer immunotherapy strategies

Prior dengue fever in people infected by Zika does not lead to worse illness

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

Researchers synthesize nanoparticles with superior antioxidant properties to treat sepsis

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News